Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,693 | -15,675 | -7,204 | -19,270 | -12,195 |
| Depreciation Amortization | 218 | 122 | 37 | 17 | 9 |
| Other Working Capital | 2,805 | 2,144 | 815 | 2,662 | 69 |
| Other Operating Activity | 2,488 | 1,712 | 682 | 3,082 | 2,949 |
| Operating Cash Flow | $-19,182 | $-11,697 | $-5,670 | $-13,509 | $-9,168 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -868 | -825 | -600 | -340 | -182 |
| Investing Cash Flow | $-868 | $-825 | $-600 | $-340 | $-182 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,737 | 231 | 1 | 56,520 | 56,512 |
| Other Financing Activity | 0 | -309 | 0 | -993 | -927 |
| Financing Cash Flow | $17,737 | $-78 | $1 | $55,527 | $55,585 |
| Beginning Cash Position | 42,565 | 42,565 | 42,565 | 887 | 887 |
| End Cash Position | 40,252 | 29,965 | 36,296 | 42,565 | 47,122 |
| Net Cash Flow | $-2,313 | $-12,600 | $-6,269 | $41,678 | $46,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,182 | -11,697 | -5,670 | -13,509 | -9,168 |
| Capital Expenditure | -868 | -825 | -600 | -340 | -182 |
| Free Cash Flow | -20,050 | -12,522 | -6,270 | -13,849 | -9,350 |